Rescinnamine

Rescinnamine structure

Rescinnamine is a pharmacological agent categorized under the class of angiotensin-converting enzyme inhibitors (ACE inhibitors) and is primarily employed for its antihypertensive effects. Its primary role is to combat hypertension by targeting and inhibiting the angiotensin-converting enzyme, thus resulting in a reduction in blood pressure.

Origin

Rescinnamine is a vinca alkaloid, a group of naturally occurring chemical compounds known for their varied pharmacological effects. It is derived from the plant species Rauwolfia serpentina and other members of the Rauwolfia genus.

Pharmacodynamics

Like other ACE inhibitors, rescinnamine works by interfering with the renin-angiotensin-aldosterone system (RAAS), a critical system in blood pressure regulation. By inhibiting the angiotensin-converting enzyme, the drug prevents the conversion of angiotensin I to its active form, angiotensin II. This leads to vasodilation and a subsequent reduction in blood pressure.

Usage

Given its antihypertensive properties, rescinnamine is used in the treatment of chronic hypertension. It can be administered alone or in combination with other antihypertensive agents, depending on the severity of the patient's condition.

Adverse Effects

As with many ACE inhibitors, some patients might experience side effects such as:

• Dry cough
• Elevated blood urea nitrogen (BUN) levels
• Hyperkalemia
• Dizziness or light-headedness
• Fatigue

Patients are advised to consult with their healthcare provider if any side effects persist or worsen.

Brand names

Moderil, Cinnasil, Anaprel

See Also

• Angiotensin-converting enzyme inhibitors
• Hypertension
• Vinca alkaloid

Rescinnamine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia